Member Info for Brighty1

Yes, bring on September and a mid 90p share price for IQE. I'm hoping for over 150p in 12 months based on what their customers are reporting. i.e. IQE are going to be reporting some very good numbers over the next year. Good luck, Brighty

Where we differ from the pharmaceutical rivals that I highlighted is that whilst they would probably capitalise on this news and issue a statement to enable them to get on the runway ready for take-off our PR approach leaves us in the hanger, not even at the departure gate - let alone on the runway. This is clearly a news event that is of interest to Sareum and its shareholders. It should be “noted” as Sareum have done in the past regarding Sierra announcements. A non-committal RNS statement to wet the appetite of the market is what is required imminently to launch Sareum to 2-3p so that when the actual milestone (or other) news hits it take us up to 10P+ and above to 20p, 30p 40p etc. Good luck, Brighty

How do you think ODX, AVCT, HEMO, SNG, NCYT, PYC etc would handle this news? They would capitalise on it. They would issue a non-committal RNS statement to wet the appetitie of the market. It's news management and Sierra is clearly of interest to Sareum share holders. Brighty

Even a bland RNS from Sareum saying that they are aware of the $150 million Sierra placing and that they hope the various parties can conclude matters with Sierra in due course, would be a good start. Brighty

The core distinction, Horse1, is that the other pharmaceutical companies I alluded to have had “news” to communicate whereas Sareum has not. It is fair to say that some of the others have had major news and that some have just been smarter with sparse news and have made the most of the eagerness of investors wishing to invest in the sector. Some on here call it a spike or ramping. My take is that some of this is clearly to do with "communication". The other pharma’s that I have highlighted are delivering mouth-watering gains, to use your phrase, which many Sareum holders on this board would welcome. In summary, during the biggest pandemic to hit the world in years Sareum has not been prepared to stick its head above the parapet on Covid – yet – apart from to do a raising for approx. £1million. Hopefully, this is about to change and Sareum will be issuing a tranche of news on numerous fronts. The following rises could be Sareum next if news is forthcoming: ODX up x 13 in 6 months, AVCT up x 15 in 6 months, HEMO up x 15 in 6 months, SNG up x 40 in 6 months, NCYT up x 75 in 6 months, PYC up x 11 in 6 months. Good luck, Brighty

Keep the faith Sareum holders! I can't believe that Sareum's management will not deliver when so many of our rivals share prices are literally rocketing. Tim would be daft to go in to an AGM / EGM situation with nothing to show. I'm sure our turn will come. Remember the following rises:
ODX 7p to 91p multiplied by x 13 in 6 months
AVCT 14p – 215p multiplied by x 15 in 6 months
HEMO 1p to 15p multiplied by x 15 in 6 months
SNG 6p to 240p multiplied x 40 in 6 months
NCYT 7p to 527p Multiplied by x 75 in 6 months
PYC 1.5p to 17p multiplied by x 11 in 6 months
Good luck, Brighty

The news expected is the Evotec in- vitro results, which commenced for 10 weeks at the start of June. That is about now, so news could come very soon. The rises we have seen with other pharma stocks have been significant:
ODX 7p to 91p in 6 months
AVCT 14p – 215p in 6 months
YGEN 7p- 24p in 6 months
HEMO 1p to 15p in 6 months
SNG 6p to 240p in 6 months
NCYT 7p to 527p in 6 months
PYC 1.5p to 10.5p in 6 months
Hopefully N4P will have similar success once news is out. Good luck, Brighty.

I love the concept of this business. With Salarius' North American distribution agreement plus Lucyd, Guident and Belluscura this is a small plc worth holding for several years. I bought in at 9p last year and believe it will be many times this figure in 3 years. The component parts of their diverse portfolio position Tek at the heart of future technology. One to hold in the filing cabinet for major gains. Good luck. Brighty

Visionary CEO required at ITV. I'm more interested in hearing where the CEO and board of ITV are taking us but as usual under this current management team it's just corporate waffle and excuses. Maybe CEO is better suited to be a Chairman than a CEO. Brighty

Only one month to go until IQE's 8th Sept H1 2020 results. More sector info out next week which should help the IQE share price, with Lumentum's on Tuesday. The most recent broker note for Lumentum has a price target increase of $11 to $107 and higher Q4 revenue and EPS estimates accordingly. IQE's numbers should reflect this success. Bring on September and a mid 90p share price for IQE. Good luck, Brighty

3.1p now. Looking increasingly good here for ALTN share holders. Hoping to see 3.5p this week ahead of news. Good luck, Brighty.

Guys, the FT will have been briefed by one or more of the bidders with a view to put a negative slant on things to keep the price suppressed. Ignore this noise, it is normal in a bid situation. It's a ploy to keep the share price low. There will be loads more of these briefings. As long as there are "bidders" rather than a "bidder" this will be good news. Good luck, Brighty

Schroders plc up their holding in BWNG from 5% to 10%. TR1. Good news. Brighty

Some big trades today including a late reported one of £35,400 GBP
Aug 4 2020, 15:20 2.95 1,200,000 2.60 2.95 Buy £35,400.00
Interesting times ahead with ALTN. Good luck, Brighty

Alanadale, based on previous turnover and profit and the corresponding share price over the last couple of years we should see an uplift to the mid to late 90p's by the end of the year, if not sooner. I think profits will be higher than expected based on what IQE's customer base has been reporting over the last 6 months. i.e. good results. Good luck, Brighty

Deemule, if the 3 bidders stay in the race - if - then this will be 90p to £1 by September 1st, if not more, in my opinion. If 1 or more drop out of the race we are looking at the 65p range. However, based on the financials it is worth much more even with the debt as this can be re-structured. My average is 23p. Good luck, Brighty.

Not sure that it is a leak, probably more to do with the point that investors are waking up to the fact that ALTN is in the right sector at the right time. Gold is at a premium and ALTN is making real progress. The ALTN share price is up x 4 already in the last year and more good news is expected soon. The momentum is with ALTN powered on by the positive sentiment surrounding the gold sector. I'm hoping to see 3.5p very soon and I will exit at 16p either because of an M&A or the current re-rate continuing. This along with TXP in the oil sector, bwng in the retail sector and Sareum in the pharma sector all have huge potential for multi bagging many times. Good luck, Brighty

2.90 hit today. Looking really promising ahead of news. Already up x 4 in last 6 months. Hope to see 3.5p shortly. 16p is my exit target. Dyor. Great opportunity here. Brighty

ALTN up 20%. News soon. Remember, last week Highland Gold was sold for £3 a share. M&A activity in the gold sector hotting up nicely. Good luck all, Brighty.

Timmy, I think sentiment in the sector is slowly shifting positvely plus yesterday natural gas prices went up by nearly 20 percent. All bodes well for a shift north in the TLW share price. Good luck, Brighty